Among key sessions at 2008 American Society of Hypertension (ASH) Annual Meeting, held in May in New Orleans, were several reports on combination therapies, including those differentiating effects among specific subgroups. More than 2,000 cardiologists with specialty interest in hypertension attended the conference.
